Uppseendeväckande resultat om behandling av myelomatos

BestPractice | Juni 26, 2018 |

PÅ ASCO 2018 lades flera intressanta nya data fram om behandling av myelomatos. I denna MEDtalk presenteras utvalda nyheter, exempelvis om Car-T-cellsterapi – en ny potent behandling.

Share
#

Senaste nyheterna

Potentiale as standard of care for patients with relapsed/refractory multiple myeloma
Potentiale as standard of care for patients with relapsed/refractory multiple myeloma
Click and hear Paul G. Richardson present the data for...
Promising activity for late-stage patients with relapses/refractory multiple myeloma
Promising activity for late-stage patients with relapses/refractory multiple myeloma
Despite recent advances in MM therapy, the disease remains incurable....